Skip to main content
SpringerLink
Log in

Skin Cancer

  • Chapter
  • First Online:
Dermatoanthropology of Ethnic Skin and Hair

Abstract

Skin cancer is the most common malignancy in the United States and tends to be more common in Caucasians in comparison to people of color (POC), though it is often associated with a worse prognosis in the latter. There is considerable variation in the incidence, clinical presentation, and behavior of skin cancer among the different ethnicities. It is important for physicians to familiarize themselves with these differences to facilitate early diagnosis and improve patient care. In addition, physicians and public education campaigns should target all individuals regardless of ethnicity, to help promote public education, preventative measures, and screening programs to help reduce the health burden from skin cancer in all communities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Jimbow K, et al. Some aspects of melanin biology: 1950–1975. J Invest Dermatol. 1976;67(1):72–89.

    Article  CAS  PubMed  Google Scholar 

  2. Montagna W, Carlisle K. The architecture of black and white facial skin. J Am Acad Dermatol. 1991;24(6 Pt 1):929–37.

    Article  CAS  PubMed  Google Scholar 

  3. Gloster HM Jr, Neal K, Skin cancer in skin of color. J Am Acad Dermatol. 2006;55(5):741–60; quiz 761-4.

    Google Scholar 

  4. Agbai ON, et al. Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public. J Am Acad Dermatol. 2014;70(4):748–62.

    Article  PubMed  Google Scholar 

  5. US Census Bureau. 2010 Census. Accessed March 20, 2016. Available from: http://www.census.gov.

  6. Bradford PT. Skin cancer in skin of color. Dermatol Nurs. 2009;21(4):170–7, 206; quiz 178.

    Google Scholar 

  7. Weishaupt C, et al. Skeletal muscle involvement in early-onset mycosis fungoides. J Am Acad Dermatol. 2011;64(6):e118–20.

    Article  PubMed  Google Scholar 

  8. Rosenberg CA, et al. Association of nonmelanoma skin cancer with second malignancy. Cancer. 2004;100(1):130–8.

    Article  PubMed  Google Scholar 

  9. Norval M. Effects of solar radiation on the human immune system. J Photochem Photobiol, B. 2001;63(1–3):28–40.

    Article  CAS  Google Scholar 

  10. Stab F, et al. Urocanic acid and its function in endogenous antioxidant defense and UV-protection in human skin. J Invest Dermatol. 1994;102(4):666.

    Google Scholar 

  11. Taylor S, et al. Taylor and Kelly’s dermatology for skin of color. 2nd ed (Edmonson KG, Brown RY, editors). New York: McGraw-Hill Education; 2016.

    Google Scholar 

  12. Gray DT, et al. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol. 1997;133(6):735–40.

    Article  CAS  PubMed  Google Scholar 

  13. Scotto J, Fears TR, Fraumeni JF. Incidence of nonmelanoma skin cancer in the United States. U.S. Dept. Health and Human Services, Public Health Service, National Institute of Health, National Cancer Institute. NIH Publication No. 83–2433 (1983), 1983.

    Google Scholar 

  14. Ishihara K, et al. Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol. 2001;6(3):109–16.

    Article  CAS  PubMed  Google Scholar 

  15. Almahroos M, Kurban AK. Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations. Skinmed 2004;3(1):29–35; quiz 35-6.

    Google Scholar 

  16. Almahroos M, Kurban AK. Ultraviolet carcinogenesis in nonmelanoma skin cancer part II: review and update on epidemiologic correlations. Skinmed. 2004;3(3):132–9.

    Article  PubMed  Google Scholar 

  17. Kotrajaras R, Kligman AM. The effect of topical tretinoin on photodamaged facial skin: the Thai experience. Br J Dermatol. 1993;129(3):302–9.

    Article  CAS  PubMed  Google Scholar 

  18. Battie C, et al. Skin cancer in skin of color: an update on current facts, trends, and misconceptions. J Drugs Dermatol. 2013;12(2):194–8.

    PubMed  Google Scholar 

  19. Scotto J, et al. Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press; 1996. pp. 1313–30.

    Google Scholar 

  20. Halder RM, Bang KM. Skin cancer in blacks in the United States. Dermatol Clin. 1988;6(3):397–405.

    CAS  PubMed  Google Scholar 

  21. Mora RG, Perniciaro C. Cancer of the skin in blacks. I. A review of 163 black patients with cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1981;5(5):535–43.

    Article  CAS  PubMed  Google Scholar 

  22. Mora RG, Perniciaro C, Lee B. Cancer of the skin in blacks. III. A review of nineteen black patients with Bowen’s disease. J Am Acad Dermatol. 1984;11(4 Pt 1):557–62.

    Google Scholar 

  23. Fleming ID, et al. Skin cancer in black patients. Cancer. 1975;35(3):600–5.

    Article  CAS  PubMed  Google Scholar 

  24. Hale EK, et al. Current concepts in the management of actinic keratosis. J Drugs Dermatol. 2004;3(2 Suppl):S3–16.

    PubMed  Google Scholar 

  25. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer. 1995;75(2 Suppl):667–73.

    Article  CAS  PubMed  Google Scholar 

  26. McCall CO, Chen SC. Squamous cell carcinoma of the legs in African Americans. J Am Acad Dermatol. 2002;47(4):524–9.

    Article  PubMed  Google Scholar 

  27. Schoeman BJ. Squamous cell carcinoma in neuropathic plantar ulcers in leprosy: another example of Marjolin’s ulcer. S Afr Med J. 1996;86(8):966–9.

    CAS  PubMed  Google Scholar 

  28. Rosen T, Tucker SB, Tschen J. Bowen’s disease in blacks. J Am Acad Dermatol. 1982;7(3):364–8.

    Article  CAS  PubMed  Google Scholar 

  29. Amir H, Mbonde MP, Kitinya JN. Cutaneous squamous cell carcinoma in Tanzania. Cent Afr J Med. 1992;38(11):439–43.

    CAS  PubMed  Google Scholar 

  30. Yakubu A, Mabogunje OA. Squamous cell carcinoma of the skin in Africans. Trop Geogr Med. 1995;47(2):91–3.

    CAS  PubMed  Google Scholar 

  31. Rudolph R, Zelac DE. Squamous cell carcinoma of the skin. Plast Reconstr Surg. 2004;114(6):82e–94e.

    Article  PubMed  Google Scholar 

  32. Mora RG. Surgical and aesthetic considerations of cancer of the skin in the black American. J Dermatol Surg Oncol. 1986;12(1):24–31.

    Article  CAS  PubMed  Google Scholar 

  33. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med. 1992;327(23):1649–62.

    Article  CAS  PubMed  Google Scholar 

  34. Della Vittoria Scarpati G, et al. Concomitant cetuximab and radiation therapy: a possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas. Mol Clin Oncol. 2016;4(4):467–471.

    Google Scholar 

  35. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262–9.

    Article  CAS  PubMed  Google Scholar 

  36. Abreo F, Sanusi ID. Basal cell carcinoma in North American blacks. Clinical and histopathologic study of 26 patients. J Am Acad Dermatol. 1991;25(6 Pt 1):1005–11.

    Google Scholar 

  37. Nguyen AV, Whitaker DC, Frodel J. Differentiation of basal cell carcinoma. Otolaryngol Clin North Am. 1993;26(1):37–56.

    CAS  PubMed  Google Scholar 

  38. Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009;10(3):207–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kimonis VE, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997;69(3):299–308.

    Article  CAS  PubMed  Google Scholar 

  40. Kimonis VE, et al. Clinical and radiological features in young individuals with nevoid basal cell carcinoma syndrome. Genet Med. 2013;15(1):79–83.

    Article  PubMed  Google Scholar 

  41. Hall J, et al. Nevoid basal cell carcinoma syndrome in a black child. J Am Acad Dermatol. 1998;38(2 Pt 2):363–5.

    Article  CAS  PubMed  Google Scholar 

  42. Martin S, Waisman M. Basal cell nevus syndrome in a black patient: report of a case and review of the literature. Arch Dermatol. 1978;114(9):1356–7.

    Article  CAS  PubMed  Google Scholar 

  43. Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome: unanswered issues. J Lab Clin Med. 1999;134(6):551–2.

    Article  CAS  PubMed  Google Scholar 

  44. Shore RE, et al. Skin cancer after X-ray treatment for scalp ringworm. Radiat Res. 2002;157(4):410–8.

    Article  CAS  PubMed  Google Scholar 

  45. Dhir A, et al. Basal cell carcinoma on the scalp of an Indian patient. Dermatol Surg. 1995;21(3):247–50.

    Article  CAS  PubMed  Google Scholar 

  46. Altman A, et al. Basal cell epithelioma in black patients. J Am Acad Dermatol. 1987;17(5 Pt 1):741–5.

    Article  CAS  PubMed  Google Scholar 

  47. Kikuchi A, Shimizu H, Nishikawa T. Clinical histopathological characteristics of basal cell carcinoma in Japanese patients. Arch Dermatol. 1996;132(3):320–4.

    Article  CAS  PubMed  Google Scholar 

  48. Kalter DC, Goldberg LH, Rosen T. Darkly pigmented lesions in dark-skinned patients. J Dermatol Surg Oncol. 1984;10(11):876–81.

    Article  CAS  PubMed  Google Scholar 

  49. Bigler C, et al. Pigmented basal cell carcinoma in Hispanics. J Am Acad Dermatol. 1996;34(5 Pt 1):751–2.

    Article  CAS  PubMed  Google Scholar 

  50. Cheng SY, Luk NM, Chong LY. Special features of non-melanoma skin cancer in Hong Kong Chinese patients: 10-year retrospective study. Hong Kong Med J. 2001;7(1):22–8.

    CAS  PubMed  Google Scholar 

  51. Tan ES, et al. Basal cell carcinoma in Singapore: a prospective study on epidemiology and clinicopathological characteristics with a secondary comparative analysis between Singaporean Chinese and Caucasian patients. Australas J Dermatol. 2015;56(3):175–9.

    Article  PubMed  Google Scholar 

  52. Zhang B, Wang N, He W. Clinicopathologic analysis of 60 cases of basal cell carcinoma. Chin Med Sci J. 1993;8(2):121–2.

    CAS  PubMed  Google Scholar 

  53. Lanehart WH, et al. Metastasizing basal cell carcinoma originating in a stasis ulcer in a black woman. Arch Dermatol. 1983;119(7):587–91.

    Article  CAS  PubMed  Google Scholar 

  54. Kidd MK, et al. Carcinoembryonic antigen in basal cell neoplasms in black patients: an immunohistochemical study. J Am Acad Dermatol. 1989;21(5 Pt 1):1007–10.

    Article  CAS  PubMed  Google Scholar 

  55. Kauvar AN, et al. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg. 2015;41(5):550–71.

    Article  CAS  PubMed  Google Scholar 

  56. Basset-Seguin N, et al. Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial. Lancet Oncol. 2015;16(6):729–36.

    Article  CAS  PubMed  Google Scholar 

  57. Migden MR, et al. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 2015;16(6):716–28.

    Article  CAS  PubMed  Google Scholar 

  58. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

    Article  PubMed  Google Scholar 

  59. Hu S, et al. UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol. 2004;140(7):819–24.

    Article  PubMed  Google Scholar 

  60. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of california cancer registry data, 1988–93. Cancer Causes Control. 1997;8(2):246–52.

    Article  CAS  PubMed  Google Scholar 

  61. Bergfelt L, et al. Incidence and anatomic distribution of cutaneous melanoma among United States Hispanics. J Surg Oncol. 1989;40(4):222–6.

    Article  CAS  PubMed  Google Scholar 

  62. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch. Available at http://seer.cancer.gov. Accessed March 28, 2016; SEER 18 2008–2012, Age-Adjusted.

  63. Jemal A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10–30.

    Article  PubMed  Google Scholar 

  64. Rhodes AR, et al. Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA. 1987;258(21):3146–54.

    Article  CAS  PubMed  Google Scholar 

  65. Holly EA, et al. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol. 1995;141(10):923–33.

    Article  CAS  PubMed  Google Scholar 

  66. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001;12(1):69–82.

    Article  CAS  PubMed  Google Scholar 

  67. Griewank KG, et al. Genetic alterations and personalized medicine in melanoma: progress and future prospects. J Natl Cancer Inst. 2014;106(2):djt435.

    Google Scholar 

  68. Elwood JM. Melanoma and sun exposure. Semin Oncol. 1996;23(6):650–66.

    CAS  PubMed  Google Scholar 

  69. Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations—US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol. 2005;141(4):477–81.

    Article  PubMed  Google Scholar 

  70. Hudson DA, Krige JE. Plantar melanoma in black South Africans. Br J Surg. 1993;80(8):992–4.

    Article  CAS  PubMed  Google Scholar 

  71. Giraud RM, Rippey E, Rippey JJ. Malignant melanoma of the skin in Black Africans. S Afr Med J. 1975;49(16):665–8.

    CAS  PubMed  Google Scholar 

  72. Bellows CF, et al. Melanoma in African-Americans: trends in biological behavior and clinical characteristics over two decades. J Surg Oncol. 2001;78(1):10–6.

    Article  CAS  PubMed  Google Scholar 

  73. Reintgen D, et al. Malignant melanoma: staging and treatment of localized and advanced disease. Cancer Control. 1999;6(4):398–404.

    CAS  PubMed  Google Scholar 

  74. Muchmore JH, Mizuguchi RS, Lee C. Malignant melanoma in American black females: an unusual distribution of primary sites. J Am Coll Surg. 1996;183(5):457–65.

    CAS  PubMed  Google Scholar 

  75. Collins RJ. Melanoma in the Chinese of Hong Kong. Emphasis on volar and subungual sites. Cancer. 1984;54(7):1482–8.

    Article  CAS  PubMed  Google Scholar 

  76. Rahman Z, Taylor SC. Malignant melanoma in African Americans. Cutis. 2001;67(5):403–6.

    CAS  PubMed  Google Scholar 

  77. Rippey JJ, Rippey E. Epidemiology of malignant melanoma of the skin in South Africa. S Afr Med J. 1984;65(15):595–8.

    CAS  PubMed  Google Scholar 

  78. Coleman WP 3rd, et al. Acral lentiginous melanoma. Arch Dermatol. 1980;116(7):773–6.

    Article  PubMed  Google Scholar 

  79. Bang KM, et al. Skin cancer in black Americans: a review of 126 cases. J Natl Med Assoc. 1987;79(1):51–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Schreiber MM, et al. The incidence of skin cancer in southern Arizona (Tucson). Arch Dermatol. 1971;104(2):124–7.

    Article  CAS  PubMed  Google Scholar 

  81. Reintgen DS, et al. Malignant melanoma in black American and white American populations. A comparative review. JAMA. 1982;248(15):1856–9.

    Article  CAS  PubMed  Google Scholar 

  82. Slingluff CL Jr, Vollmer R, Seigler HF. Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol. 1990;45(2):91–8.

    Article  PubMed  Google Scholar 

  83. Byrd KM, et al. Advanced presentation of melanoma in African Americans. J Am Acad Dermatol. 2004;50(1):21–4; discussion 142-3.

    Google Scholar 

  84. Stevens NG, Liff JM, Weiss NS. Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer. 1990;45(4):691–3.

    Article  CAS  PubMed  Google Scholar 

  85. Durbec F, et al. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol. 2012;166(4):727–39.

    Article  CAS  PubMed  Google Scholar 

  86. Swerdlow AJ, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed). 1986;292(6535):1555–9.

    Article  CAS  Google Scholar 

  87. Rodenas JM, et al. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain. Am J Epidemiol. 1997;145(11):1020–9.

    Article  CAS  PubMed  Google Scholar 

  88. Coleman WP 3rd, et al. Nevi, lentigines, and melanomas in blacks. Arch Dermatol. 1980;116(5):548–51.

    Article  PubMed  Google Scholar 

  89. Black WC, Goldhahn RT Jr, Wiggins C. Melanoma within a southwestern Hispanic population. Arch Dermatol. 1987;123(10):1331–4.

    Article  CAS  PubMed  Google Scholar 

  90. Pennello G, Devesa S, Gail M. Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks. Cancer Epidemiol Biomarkers Prev. 2000;9(3):291–7.

    CAS  PubMed  Google Scholar 

  91. Pathak DR, et al. Malignant melanoma of the skin in New Mexico 1969–1977. Cancer. 1982;50(7):1440–6.

    Article  CAS  PubMed  Google Scholar 

  92. (NCCN), N.C.C.N. NCCN Guidlines Melanoma. Melanoma Version 2.2016 2016 [cited 2016 5.30.2016]; Available from: https://www.nccn.org/.

  93. Vayer A, Lefor AT. Cutaneous melanoma in African-Americans. South Med J. 1993;86(2):181–2.

    Article  CAS  PubMed  Google Scholar 

  94. Hudson DA, Krige JE, Stubbings H. Plantar melanoma: results of treatment in three population groups. Surgery. 1998;124(5):877–82.

    Article  CAS  PubMed  Google Scholar 

  95. Hudson DA, Krige JE. Melanoma in black South Africans. J Am Coll Surg. 1995;180(1):65–71.

    CAS  PubMed  Google Scholar 

  96. Hu S, et al. Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida. Arch Dermatol. 2006;142(6):704–8.

    Article  PubMed  Google Scholar 

  97. Johnson DS, et al. Malignant melanoma in non-Caucasians: experience from Hawaii. Surg Clin North Am. 2003;83(2):275–82.

    Article  PubMed  Google Scholar 

  98. Cockburn MG, Zadnick J, Deapen D. Developing epidemic of melanoma in the Hispanic population of California. Cancer. 2006;106(5):1162–8.

    Article  PubMed  Google Scholar 

  99. Crowley NJ, et al. Malignant melanoma in black Americans. A trend toward improved survival. Arch Surg. 1991;126(11):1359–64; discussion 1365.

    Google Scholar 

  100. Swan MC, Hudson DA. Malignant melanoma in South Africans of mixed ancestry: a retrospective analysis. Melanoma Res. 2003;13(4):415–9.

    Article  CAS  PubMed  Google Scholar 

  101. Chen YJ, et al. Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol. 1999;41(6):945–9.

    Article  CAS  PubMed  Google Scholar 

  102. Hu S, et al. Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol. 2009;145(12):1369–74.

    Article  PubMed  Google Scholar 

  103. Kosary C, Ries L, Miller B. SEER cancer statistics review, 1973–1992: tables and graphs. Bethesda (MD): National Cancer Institute; 1995.

    Google Scholar 

  104. Zell JA, et al. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008;26(1):66–75.

    Article  PubMed  Google Scholar 

  105. Willemze R, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–85.

    Article  CAS  PubMed  Google Scholar 

  106. Bradford PT, et al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Weinstock MA, Horm JW. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA. 1988;260(1):42–6.

    Article  CAS  PubMed  Google Scholar 

  108. Akaraphanth R, Douglass MC, Lim HW. Hypopigmented mycosis fungoides: treatment and a 6(1/2)-year follow-up of 9 patients. J Am Acad Dermatol. 2000;42(1 Pt 1):33–9.

    Article  CAS  PubMed  Google Scholar 

  109. Sun G, et al. Poor prognosis in non-caucasian patients with early-onset mycosis fungoides. J Am Acad Dermatol. 2009;60(2):231–5.

    Article  PubMed  Google Scholar 

  110. Lambroza E, et al. Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases. J Am Acad Dermatol. 1995;32(6):987–93.

    Article  CAS  PubMed  Google Scholar 

  111. Stone ML, et al. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis. 2001;67(2):133–8.

    CAS  PubMed  Google Scholar 

  112. Agar NS, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28(31):4730–9.

    Article  PubMed  Google Scholar 

  113. Morton LM, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood. 2006;107(1):265–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Schwartz RA, et al. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol. 2008;59(2):179–206; quiz 207-8.

    Google Scholar 

  115. Rouhani P, et al. Cutaneous soft tissue sarcoma incidence patterns in the U.S.: an analysis of 12,114 cases. Cancer. 2008;113(3):616–27.

    Article  PubMed  Google Scholar 

  116. Stallone G, et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med. 2005;352(13):1317–23.

    Article  CAS  PubMed  Google Scholar 

  117. Gloster HM Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35(3 Pt 1):355–74; quiz 375-6.

    Google Scholar 

  118. Kreicher KL, et al. Incidence and survival of primary dermatofibrosarcoma protuberans in the United States. Dermatol Surg. 2016;42(Suppl 1):S24–31.

    Article  CAS  PubMed  Google Scholar 

  119. Wang C, et al. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients. Medicine (Baltimore). 2015;94(17):e773.

    Article  Google Scholar 

  120. Ugurel S, et al. Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up. Clin Cancer Res. 2014;20(2):499–510.

    Article  CAS  PubMed  Google Scholar 

  121. Albores-Saavedra J, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37(1):20–7.

    Article  PubMed  Google Scholar 

  122. Czapiewski P, Biernat W. Merkel cell carcinoma—recent advances in the biology, diagnostics and treatment. Int J Biochem Cell Biol. 2014;53:536–46.

    Article  CAS  PubMed  Google Scholar 

  123. Prieto Munoz I, et al. Merkel cell carcinoma from 2008 to 2012: reaching a new level of understanding. Cancer Treat Rev. 2013;39(5):421–9.

    Article  PubMed  Google Scholar 

  124. Ratner D, et al. Merkel cell carcinoma. J Am Acad Dermatol. 1993;29(2 Pt 1):143–56.

    Article  CAS  PubMed  Google Scholar 

  125. Cassler NM, et al. Merkel cell carcinoma therapeutic update. Curr Treat Options Oncol. 2016;17(7):36.

    Article  PubMed  Google Scholar 

  126. Martel-Jantin C, et al. Molecular epidemiology of merkel cell polyomavirus: evidence for geographically related variant genotypes. J Clin Microbiol. 2014;52(5):1687–90.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Song PI, et al. The clinical profile of Merkel cell carcinoma in mainland China. Int J Dermatol. 2012;51(9):1054–9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Boston University Medical Center, 609 Albany St, Boston, MA, 02120, USA

    Ali Al-Haseni & Debjani Sahni

Authors
  1. Ali Al-Haseni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Debjani Sahni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Debjani Sahni .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Center for Ethnic Skin, Boston University, Boston, Massachusetts, USA

    Neelam A. Vashi

  2. University of California, San Francisco, San Francisco, California, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Al-Haseni, A., Sahni, D. (2017). Skin Cancer. In: Vashi, N., Maibach, H. (eds) Dermatoanthropology of Ethnic Skin and Hair. Springer, Cham. https://doi.org/10.1007/978-3-319-53961-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53961-4_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53960-7

  • Online ISBN: 978-3-319-53961-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation